Krasney Karen

Nile Therapeutics, Inc

EVP, General Counsel

Avg. Two Year Performance

(25%) Avg. Purchase Return (12%) Compound

No Sale Track Record

Holdings: 20.05K shares

Last Three Months: 23-Aug-24 -- 22-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Biotechnology

Drugs

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions